Product Code: GVR-4-68039-977-4
Dermatome Device Market Growth & Trends
The global dermatome device market size is expected to reach USD 231.0 million by 2030, registering a CAGR of 5.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. There is a significant rise in the number of cosmetic procedures that are being carried out, globally. This is expected to boost the growth of the industry over the forecast period. In addition, factors, such as the rise in burn injuries and skin infections, are also driving industry growth. Skin grafting is an adequate treatment that is required in cosmetic surgery. A dermatome is used to carry out the skin grafting procedure in cosmetic surgery.
Thus, a rise in the number of cosmetic surgeries is leading to an increase in the sales of dermatome devices. For instance, according to the Aesthetic Society, in 2021, on average a plastic surgeon performed 320 surgical procedures, as compared to 220 in 2020 in the U.S. Dermatome device are also used in skin reconstitution in patients with trauma or grade 3 burns. The rising number of accidents and burn cases is therefore majorly contributing to a rise in product sales. For instance, according to an article posted by the American Burn Association in 2020, about 3,500 people are fatally injured in a fire or burn accident each year in the U.S.
The industry experienced a negative impact due to the COVID-19 pandemic majorly due to the postponement of elective procedures. However, the opening of the economies and the increasing focus of surgeons and the medical fraternity that was badly hit by the pandemic to recover from the losses faced led to a quick recovery of the industry in 2021. Furthermore, the industry is expected to flourish at a much faster pace owing to a rapid rise in the adoption of cosmetic surgeries.
Dermatome Device Market Report Highlights
- The powered dermatome device segment held the highest share in 2022 owing to the increased adoption rate across different applications
- The chronic burn care segment accounted for the highest share in 2022 due to a rise in burn cases in both developed and developing countries
- The plastic surgery segment is expected to register the fastest CAGR over the forecast period as a large number of people are opting for these procedures
- The hospitals segment held the largest share in 2022 as a majority of the medical procedures that require dermatomes are covered under one setting for different applications
- The Ambulatory Surgical Centers (ASCs) segment is expected to record the maximum growth over the forecast period owing to the rising popularity of plastic surgeries in these settings
- North America was the dominant region in 2022 owing to the presence of well-established healthcare infrastructure
- However, Asia Pacific is expected to have the fastest CAGR during the forecast period mainly due to the increasing number of burn cases and rising adoption of plastic surgeries
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End-Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Application Outlook
- 2.2.3. End-use Outlook
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Dermatome Device Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rise in number of burn cases
- 3.4.1.2. Increase in number of pressure ulcers and skin infections
- 3.4.1.3. Technological advancements
- 3.4.2. Market restraint analysis
- 3.4.2.1. Lack of skilled professionals
- 3.4.3. Industry challenges
- 3.5. Dermatome Device Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Dermatome Device: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Drum Dermatome Device
- 4.1.2. Knife Dermatome Device
- 4.1.3. Powered Dermatome Device
- 4.1.3.1. Pneumatic Dermatome Device
- 4.1.3.2. Battery Operated Dermatome Device
- 4.1.3.3. Electric Dermatome Device
- 4.2. Product Market Share, 2021 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Dermatome Device Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 4.5.1. Drum Dermatome Device
- 4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
- 4.5.2. Knife Dermatome Device
- 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3. Powered Dermatome Device
- 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3.2. Pneumatic Dermatome Device
- 4.5.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3.3. Battery Operated Dermatome Device
- 4.5.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3.4. Electric Dermatome Device
- 4.5.3.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Dermatome Device: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Plastic Surgery
- 5.1.2. Reconstructive Surgery
- 5.1.3. General Surgery
- 5.1.4. Chronic Burn Care Treatments
- 5.1.5. Others
- 5.2. Application Market Share, 2021 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Dermatome Device Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 5.5.1. Plastic Surgery
- 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.2. Reconstructive Surgery
- 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.3. General Surgery
- 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.4. Chronic Burn Care Treatments
- 5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.5. Others
- 5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 6. End-Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Ambulatory Surgical Centers
- 6.1.3. Dermatology Clinics
- 6.1.4. Others
- 6.2. End-Use Market Share, 2021 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Dermatome Device Market by End-Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 6.5.2. Ambulatory Surgical Centers
- 6.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 6.5.3. Dermatology Clinics
- 6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 6.5.4. Others
- 6.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 7. Dermatome Device Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2021 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2021
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts and Trend Analysis, 2017 to 2030
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8. Europe
- 7.8.1. UK
- 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.6. Denmark
- 7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.7. Sweden
- 7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.8. Norway
- 7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.2. China
- 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.3. India
- 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.4. Australia
- 7.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.5. South Korea
- 7.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.6. Thailand
- 7.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11. MEA
- 7.11.1. South Africa
- 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.2. Saudi Arabia
- 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.4. Kuwait
- 7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.2.2. Market Leaders
- 8.2.3. Emerging Players
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2021
- 8.3.4. Zimmer Biomet
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Integra Lifesciences
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. B. Braun Melsungen AG
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Surtex Instruments Ltd.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Aesculap, Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Shaanxi Xingmao Industry Co., Ltd.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Aygun Surgical Instruments Co., Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Humeca BV
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Nouvag AG
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Novo Surgical Inc.
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives